Authors


Robert J. Stout, RPh

Latest:

“Pharmacists, lobby your legislators!” says BOP insider

If you want improved working conditions in the pharmacy, you're gonna hafta help.





Lauren Heroux-Camirand

Latest:

How pharmacists should be fighting the heroin epidemic

Once we as individuals in the healthcare profession finally begin to accept addiction as a disease and not a moral failing, the affected individuals will have a better chance at recovery and we will gain a better understanding of this epidemic.



Liz Meszaros

Latest:

Pharmacy of tomorrow

Tomorrow's pharmacists and pharmacies will need to find ways to increase profit margins by reducing the cost of prescribing, embracing technology, and focusing more on patient counseling, immunizations, education, and other offshoots of their clinical expertise.





Heide Aungst

Latest:

Niche pharmacies serve children and the elderly

Specialty pharmacies are developing to meet the growing needs of children and senior citizens.


Jill Wechsler

Latest:

User Fees Reauthorized for FDA

FDA keeps its user fees but fails to gain important reforms.


Julia Talsma, Editor-in-Chief

Latest:

Drug Topics CPE accreditor begins 3-year service to AACP

During the American Association of Colleges of Pharmacy (AACP) Annual Meeting in Kissimmee, Fla. in mid-July, Jill Fitzgerald, PharmD, who is Drug Topics CPE accreditor, was sworn in as chair-elect to the AACP Continuing Professional Education Section.



Drug Topics readers

Latest:

Letters

Readers have their say on unionization, fair reimbursement, and self-regulation.



Leah Perry

Latest:

Pipeline drugs 2010

Categories to watch in this year's diverse drug pipeline include oral agents to treat multiple sclerosis and a host of new diabetes, cardiovascular, and pain-management products.


David D. Trang, PharmD, MBA

Latest:

Is the pharmacist shortage over?

Increasing enrollment in pharmacy schools and changing economic factors appear to have eased the national pharmacist shortage. In order to plan appropriately for all stakeholders, we need to quantify the numbers when we talk about a pharmacist shortage.


Ernest P. Gates Jr., RPh, FASCP, FIACP, FACA

Latest:

Opinion: Compounding Pharmacists Must Rebuild the Industry

Four steps that compounding pharmacists must take to restore their credibility.


Michael J. Schuh, BS, PharmD, MBA

Latest:

A retail pharmacist examines the consequences of working in a fishbowl

Doctors don't do it. Attorneys don't do it. Physical therapists, insurance agents, title agents, audiologist, and nurse practitioners don't do it. Who came up with the fishbowl model of retail pharmacy anyway?


Ken Krizner

Latest:

Top Challenges in Managing Diabetes

Cost, education, self-monitoring, and more. 


Christine Blank

Latest:

Continuous Glucose Monitors Useful for Predicting Pre-Diabetes

When employed as a prescreening tool, care must be taken to avoid overdiagnosis of healthy individuals without diabetes.


Ron Rajecki

Latest:

Drug Topics' 2010 business outlook survey

Respondents to this year's business outlook survey are generally upbeat about the business their pharmacies are doing and their prospects for the coming year.


From staff reports

Latest:

FDA warns against prolonged use of magnesium sulfate to stop preterm labor

FDA advised healthcare professionals not to use magnesium sulfate injection for more than 5-7 days to stop preterm labor in pregnant women.


B. Douglas Hoey, RPh, MBA

Latest:

Q&A: Medicare Price Negotiations Put Pharmacies, Patient Access at Risk | AAP 2025

A discussion with Douglas Hoey, RPh, MBA, CEO of NCPA, at AAP 2025.



Fred Gebhart

Latest:

Launch Your Own Diabetes Prevention Program

The CDC estimates that 83 million Americans have prediabetes and that 84% of them don’t know it and community pharmacy can play a major role in preventing diabetes.



Keith W. Trettin, RPh, MBA

Latest:

Drug delivery systems: Multiple- vs. single-dose

All hospital and health systems must decide whether to use multiple-dose vials or single-dose vials of drugs, a decision that usually rests on two considerations: Cost reduction and patient safety. The pros and cons of the two systems lead to an inescapable conclusion.


James M. Scanlon, BS, RPh

Latest:

Problem-solving in the pharmacy

Confronted with these three common scenarios in your daily practice of pharmacy, what would you do?

© 2025 MJH Life Sciences

All rights reserved.